Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-26

Clinical Trial Update: Butyrate-enriched Triglyceride and Diabetes Prevention [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating a butyrate-enriched triglyceride for diabetes prevention. The study targets individuals with prediabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butyrate-enriched triglyceride

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Type 2 Diabetes, PreDiabetes | NA | Status: RECRUITING